Qian, Jin
Fu, Liyan
Wu, Xiaoli
Wang, Zhiying
Wang, Hualin
Zeng, Yan
Cheng, Guirong
Deng, Fei
Shen, Shu http://orcid.org/0000-0002-0013-5365
Funding for this research was provided by:
Key Technologies Research and Development Program (2018YFE0200400)
National Natural Science Foundation of China (U20A20135)
EVAg-Global project (871029)
Article History
Received: 10 February 2023
Accepted: 17 April 2023
First Online: 24 May 2023
Declarations
:
: Animal experiments were approved by the ethics committee of Wuhan Institute of Virology, Chinese Academy of Sciences under the approval number WIVA33202004.
: The authors of this manuscript have the following competing interests: Jin Qian, Shu Shen, Fei Deng, Liyan Fu, Xiaoli Wu, Zhiying Wang, and Guirong Cheng are the inventors in a pending patent application filed on the reported antibodies. The other authors have no relevant financial or non-financial interests to disclose.